Matrix metalloproteinases gene variants in idiopathic disseminated bronchiectasis

Journal of Investigative Medicine

Volumn 57, Issue 3, 2009, Pages 500-503

  Stankovic, Marija ^a   Nikolic, Aleksandra ^a   Divac, Aleksandra ^a   Rakicevic, Ljiljana ^a   Tomovic, Andrija ^b   Mitic Milikic, Marija ^c   Nagorni Obradovic, Ljudmila ^c   Grujic, Milan ^c   Petrovic Stanojevic, Natasa ^d   Andjelic Jelic, Marina ^d   Dopudja Pantic, Vesna ^d   Radojkovic, Dragica ^a  

^a INSTITUTE OF MOLECULAR GENETICS AND GENETIC ENGINEERING   (Serbia)

^b ETH ZURICH   (Switzerland)

^c University Clinical Center of Serbia   (Macedonia)

^d ZVEZDARA UNIVERSITY MEDICAL CENTER   (Serbia)

Author keywords

Association; Idiopathic disseminated bronchiectasis; MMP1; MMP9; Promoter polymorphisms

Indexed keywords

GELATINASE B; INTERSTITIAL COLLAGENASE;

ADULT; ALLELE; ARTICLE; BRONCHIECTASIS; CLINICAL ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE IDENTIFICATION; GENETIC ASSOCIATION; GENETIC RISK; GENETIC VARIABILITY; GENOTYPE; HETEROZYGOTE; HOMOZYGOTE; HUMAN; MALE; PATHOGENESIS;

BRONCHIECTASIS; DNA MUTATIONAL ANALYSIS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 9; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;

EID: 67650702553     PISSN: 17088267     EISSN: None     Source Type: Journal    
DOI: 10.2310/JIM.0b013e318198277c     Document Type: Article

References (37)

1. King PT, Holdsworth SR, Freezer NJ, et al. Characterisation of the onset and presenting clinical features of adult bronchiectasis. Respir Med. 2006;100:2183-2189.
2. O'Brien C, Guest PJ, Hill SL, et al. Physiological and radiological characterisation of patients diagnosed with chronic obstructive pulmonary disease in primary care. Thorax. 2000;55:635-642.
3. Pasteur MC, Helliwell SM, Houghton SJ, et al. An investigation into causative factors in patients with bronchiectasis. Am J Respir Crit Care Med. 2000;162:1277-1284.
4. Shoemark A, Ozerovitch L, Wilson R. Aetiology in adult patients with bronchiectasis. Respir Med. 2007;101:1163-1170.
5. Sepper R, Konttinen YT, Sorsa T, et al. Gelatinolytic and type IV collagenolytic activity in bronchiectasis. Chest. 1994;106:1129-1133.
6. Maisi P, Prikk K, Sepper R, et al. Soluble membrane-type 1 matrix metalloproteinase (MT1-MMP) and gelatinase A (MMP-2) in induced sputum and bronchoalveolar lavage fluid of human bronchial asthma and bronchiectasis. APMIS. 2002;110:771-782.
7. Takemura M, Niimi A, Minakuchi M, et al. Bronchial dilatation in asthma: relation to clinical and sputum indices. Chest. 2004;125: 1352-1358.
8. Segura-Valdez L, Pardo A, Gaxiola M, et al. Upregulation of gelatinases A and B, collagenases 1 and 2, and increased parenchymal cell death in COPD. Chest. 2000;117:684-694.
9. Cataldo DD, Gueders M, Munaut C, et al. Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases mRNA transcripts in the bronchial secretions of asthmatics. Lab Invest. 2004;84:418-424.
10. Shapiro SD, Senior RM. Matrix metalloproteinases. Matrix degradation and more. Am J Respir Cell Mol Biol. 1999;20:1100-1102.
11. Greenlee KJ, Werb Z, Kheradmand F. Matrix metalloproteinases in lung: multiple, multifarious, and multifaceted. Physiol Rev. 2007;87:69-98.
12. Zheng L, Lam WK, Tipoe GL, et al. Overexpression of matrix metalloproteinase-8 and -9 in bronchiectatic airways in vivo. Eur Respir J. 2002;20:170-176.
13. Rutter JL, Mitchell TI, Buttice G, et al. Brinckerhoff CE. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res. 1998;58:5321-5325.
14. Heighway J, Bowers NL, Smith S, et al. The use of allelic expression differences to ascertain functional polymorphisms acting in cis: analysis of MMP1 transcripts in normal lung tissue. Ann Hum Genet. 2005; 69:127-133.
15. Decock J, Paridaens R, Ye S. Genetic polymorphisms of matrix metalloproteinases in lung, breast and colorectal cancer. Clin Genet. 2008;73:197-211.
16. Zhang B, Ye S, Herrmann SM, et al. Functional polymorphism in the regulatory region of gelatinase B gene in relation to severity of coronary atherosclerosis. Circulation. 1999;99:1788-1794.
17. Ito I, Nagai S, Handa T, et al. Matrix metalloproteinase-9 promoter polymorphism associated with upper lung dominant emphysema. Am J Respir Crit Care Med. 2005;172:1378-1382.
18. Nakashima K, Hirota T, Obara K, et al. A functional polymorphism in MMP-9 is associated with childhood atopic asthma. Biochem Biophys Res Commun. 2006;344:300-307.
19. Korkko J, Annunen S, Pihlajamaa T, et al. Conformation sensitive gel electrophoresis for simple and accurate detection of mutations: comparison with denaturing gradient gel electrophoresis and nucleotide sequencing. Proc Natl Acad Sci U S A. 1998;95:1681-1685.
20. Radojkovic D, Kusic J. Silver Staining of DGGE Gels. Clin Chem. 2000;46:883-884.
21. Lenth RV (2006) Java Applets for Power and Sample Size [Computer software]. Retrieved October, 6, 2008, from [http://www.stat.uiowa.edu/ ∼rlenth/Power].
22. Perneger TV. What's wrong with Bonferroni adjustments. BMJ. 1998;18:1236-1238.
23. Casals T, De-Gracia J, Gallego M, et al. Bronchiectasis in adult patients: an expression of heterozygosity for CFTR gene mutations? Clin Genet. 2004;65:490-495.
24. Patuzzo C, Gile LS, Zorzetto M, et al. Tumor necrosis factor gene complex in COPD and disseminated bronchiectasis. Chest. 2001;119: 315-316.
25. Hoening JM, Heisey DM. The abuse of power: The pervasive fallacy of power calculations for data analysis. Am Stat. 2001;55:19-24.
26. Dunleavey L, Beyzade S, Ye S. Rapid genotype analysis of the matrix metalloproteinase-1 gene 1G/2G polymorphism that is associated with risk of cancer. Matrix Biol. 2000;19:175-177.
27. Joos L, He JQ, Shepherdson MB, et al. The role of matrix metalloproteinase polymorphisms in the rate of decline in lung function. Hum Mol Genet. 2002;11:569-576.
28. Culpitt SV, Rogers DF, Traves SL, et al. Sputum matrix metalloproteases: comparison between chronic obstructive pulmonary disease and asthma. Respir Med. 2005;99:703-710.
29. Imai K, Dalal SS, Chen ES, et al. Human collagenase (matrix metalloproteinase-1) expression in the lungs of patients with emphysema. Am J Respir Crit Care Med. 2001;163:786-791.
30. Zhu Y, Spitz MR, Lei L, et al. A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter enhances lung cancer susceptibility. Cancer Res. 2001;61:7825-7829.
31. Su L, Zhou W, Park S, et al. Matrix metalloproteinase-1 promoter polymorphism and lung cancer risk. Cancer Epidemiol Biomarkers Prev. 2005;14:567-570.
32. Fang S, Jin X, Wang R, et al. Polymorphisms in the MMP1 and MMP3 promoter and non-small cell lung carcinoma in North China. Carcinogenesis. 2005;26:481-486.
33. Parks WC, Shapiro SD. Matrix metalloproteinases in lung biology. Respir Res. 2001;2:10-19.
34. Finlay GA, O'Driscoll LR, Russell KJ, et al. Matrix metalloproteinase expression and production by alveolar macrophages in emphysema. Am J Respir Crit Care Med. 1997;156:240-247.
35. Mautino G, Oliver N, Chanez P, et al. Increased release of matrix metalloproteinase-9 in bronchoalveolar lavage fluid and by alveolar macrophages of asthmatics. Am J Respir Cell Mol Biol. 1997;17: 583-591.
36. Prikk K, Maisi P, Pirilä E, et al. In vivo collagenase-2 (MMP-8) expression by human bronchial epithelial cells and monocytes/ macrophages in bronchiectasis. J Pathol. 2001;194:232-238.
37. Lee J, Kim HR, Min JW, et al. Lack of association between matrix metalloproteinase 8 promoter polymorphism and bronchiectasis in Koreans. J Korean Med Sci. 2007;22:667-671.